{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:34Z","timestamp":1792788574641,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejmg.2023.104698","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T11:01:49Z","timestamp":1673694109000},"page":"104698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Adult patient diagnosed with NADSYN1 associated congenital NAD deficiency and analysis of NAD levels to be published in: European Journal of Medical Genetics"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7019-8564","authenticated-orcid":false,"given":"Emilie","family":"Erbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Lohman","family":"Brasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan Meldgaard","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2023.104698_bib1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41436-018-0296-x","article-title":"Identification of clinically actionable variants from genome sequencing of families with congenital heart disease","volume":"21","author":"Alankarage","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejmg.2023.104698_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/jpet.116.239459","article-title":"Luteolinidin protects the postischemic heart through CD38 inhibition with preservation of NAD(P)(H)","volume":"361","author":"Boslett","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmg.2023.104698_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10545-007-0396-2","article-title":"Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase","volume":"30","author":"Christensen","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejmg.2023.104698_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13845-4","article-title":"Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+ synthetases","volume":"11","author":"Chuenchor","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmg.2023.104698_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039115","article-title":"Glutamine versus ammonia utilization in the NAD synthetase family","volume":"7","author":"de Ingeniis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmg.2023.104698_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115219","article-title":"Biallelic variants in KYNU cause a multisystemic syndrome with hand hyperphalangism","volume":"133","author":"Ehmke","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.ejmg.2023.104698_bib7","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1074\/jbc.M209203200","article-title":"Molecular identification of human glutamine- and ammonia-dependent NAD synthetases. Carbon-nitrogen hydrolase domain confers glutamine dependency","volume":"278","author":"Hara","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmg.2023.104698_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00246","article-title":"Nicotinamide mononucleotide: a promising molecule for therapy of diverse diseases by targeting NAD+ metabolism","volume":"8","author":"Hong","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmg.2023.104698_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCRESAHA.109.203703","article-title":"Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes","volume":"105","author":"Hsu","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmg.2023.104698_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tma.2021.09.001","article-title":"A single oral supplementation of nicotinamide within the daily tolerable upper level increases blood NAD+ levels in healthy subjects","volume":"5","author":"Ito","year":"2021","journal-title":"Transl Med Aging"},{"key":"10.1016\/j.ejmg.2023.104698_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","article-title":"NAD + homeostasis in health and disease","volume":"2","author":"Katsyuba","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.ejmg.2023.104698_bib12","series-title":"Safety of High-Dose Nicotinamide: A Review","author":"Knip","year":"2000"},{"key":"10.1016\/j.ejmg.2023.104698_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.62765","article-title":"Further description of two patients with biallelic variants in NADSYN1 in association with cardiac and vertebral anomalies","author":"Kortbawi","year":"2022","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2023.104698_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101615","article-title":"Disruptive NADSYN1 variants implicated in congenital vertebral malformations","volume":"12","author":"Lin","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.ejmg.2023.104698_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03421-7","article-title":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD + in healthy middle-aged and older adults","volume":"9","author":"Martens","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmg.2023.104698_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061616","article-title":"Nicotinamide riboside-the current state of Research and therapeutic uses","volume":"12","author":"Mehmel","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmg.2023.104698_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113939","article-title":"Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues","volume":"9","author":"Mori","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmg.2023.104698_bib18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cmet.2014.04.002","article-title":"Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle","volume":"19","author":"Pirinen","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmg.2023.104698_bib19","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA118.002241","article-title":"Kinetics and structural features of dimeric glutamine-dependent bacterial NAD synthetases suggest evolutionary adaptation to available metabolites","volume":"293","author":"Santos","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmg.2023.104698_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/genes12060879","article-title":"A homozygous deletion of exon 5 of KYNU resulting from a maternal chromosome 2 isodisomy (UPD2) causes catel-manzke-syndrome\/VCRL syndrome","volume":"12","author":"Sch\u00fcle","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.ejmg.2023.104698_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa1616361","article-title":"NAD deficiency, congenital malformations, and niacin supplementation","volume":"377","author":"Shi","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmg.2023.104698_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajhg.2019.12.006","article-title":"Bi-Allelic mutations in NADSYN1 cause multiple organ defects and expand the genotypic spectrum of congenital NAD deficiency disorders","volume":"106","author":"Szot","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2023.104698_bib23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/humu.24211","article-title":"New cases that expand the genotypic and phenotypic spectrum of Congenital NAD Deficiency Disorder","volume":"42","author":"Szot","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejmg.2023.104698_bib24","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721223000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721223000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:53:56Z","timestamp":1761710036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721223000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1769721223000046"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2023.104698","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult patient diagnosed with NADSYN1 associated congenital NAD deficiency and analysis of NAD levels to be published in: European Journal of Medical Genetics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2023.104698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104698"}}